Showing results (131-140 of 295) with videos related to

Sort By:
Pageof 30
Respiration; International Review of Thoracic Diseases|February 12, 2004
Interferon gamma-1b as therapy for idiopathic pulmonary fibrosis. An intrapatient analysisSteven D Nathan, Scott D Barnett, Brian Moran, et al.
Pulmonary Circulation|October 4, 2024
COPD associated pulmonary hypertension: A post hoc analysis of the PERFECT studySteven D Nathan, Victoria Lacasse, Heidi Bell, et al.
Pulmonary Circulation|December 29, 2022
Pulmonary hypertension in interstitial lung disease: Clinical trial design and endpoints: A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative-Group 3 Pulmonary HypertensionSteven D Nathan, Peter Fernandes, Mitchell Psotka, et al.
Advances in Therapy|July 5, 2022
The Antifibrotic Effects of Inhaled Treprostinil: An Emerging Option for ILDMartin Kolb, Stylianos E Orfanos, Chris Lambers, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|August 24, 2022
The 6-min walk test as a primary end-point in interstitial lung diseaseSergio Harari, Athol U Wells, Wim A Wuyts, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|December 1, 2021
Agreement Between the TEG 6s and TEG 5000 Analyzers in Extracorporeal Membrane OxygenationAbhimanyu Chandel, Mehul Desai, Christopher S King, et al.
Respiratory Medicine|May 5, 2018
Sildenafil added to pirfenidone in patients with advanced idiopathic pulmonary fibrosis and risk of pulmonary hypertension: A Phase IIb, randomised, double-blind, placebo-controlled study - Rationale and study designJürgen Behr, Steven D Nathan, Sergio Harari, et al.
Respiration; International Review of Thoracic Diseases|August 17, 2018
Identifying Barriers to Idiopathic Pulmonary Fibrosis Treatment: A Survey of Patient and Physician ViewsToby M Maher, Jeffrey J Swigris, Michael Kreuter, et al.
Respiratory Medicine|March 5, 2010
Prevalence and impact of coronary artery disease in idiopathic pulmonary fibrosisSteven D Nathan, Ashwin Basavaraj, Cristina Reichner, et al.
Respiratory Medicine|November 26, 2016
Idiopathic interstitial pneumonia-associated pulmonary hypertension: A target for therapy?Steven D Nathan, Jürgen Behr, Vincent Cottin, et al.
Pageof 30